Abstract

Proteins catalysing the transport of molecules across biological membranes are vital for organisms in all kingdoms of life. These proteins are needed for the uptake of nutrients and the efflux of signalling molecules and toxic compounds. In the human opportunistic pathogen Candida albicans, efflux proteins can translocate antifungal drugs, such as fluconazole, and confer drug resistance. There are two main families of membrane proteins involved in drug transport, the major facilitator superfamily (MFS) and the ATP-binding cassette (ABC) proteins. Both types of protein possess multiple membrane spanning α-helices in transmembrane domains (TMDs), and ABC proteins, in addition, contain cytosolic nucleotide-binding domains (NBDs) involved in ATP hydrolysis. ABC proteins, and to a lesser extent MFS proteins, have broad substrate specificities that are determined by the structure and arrangement of the transmembrane α-helices. The multidrug transporter most often associated with drug resistance of C. albicans clinical isolates is ABC protein Cdr1. This is a pleiotropic drug resistance (PDR) ABC protein with domain arrangement NBD1-TMD1-NBD2-TMD2 and unique large extracellular loops between transmembrane α-helices that may be important for pump function. There is no crystal structure for Cdr1, but X-ray structures of related proteins indicate that unique interactions between conserved elements of the TMDs and the NBDs are important for pump function.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.